Tech Talks Daily

• 3272: Inside Illumio's Global Ransomware Report - Building Real-World Cyber Resilience

  How prepared is your business for a ransomware attack? Not just to prevent it, but to continue operating when it happens. In this episode, I sit down with Trevor Dearing, Director of Critical Infrastructure at Illumio, to discuss the latest findings from their global ransomware report and what they reveal about cyber resilience. Trevor shares insight from a survey of more than 3,000 organisations across multiple sectors. The most concerning figure is that 58 percent of those impacted by ransomware were forced to halt operations. That number has risen sharply from 43 percent just two years ago. Despite this, many businesses in the UK still avoid reporting attacks, often due to fears around reputational damage or potential retaliation. Trevor explains why that reluctance is misguided and how public support, improved infrastructure, and more explicit government guidance could encourage more transparency. We also explore the rise of containment as a more practical and cost-effective approach than prevention alone. Rather than trying to stop every attack at the perimeter, organisations are learning how to isolate and limit damage quickly. Trevor explains how zero trust architecture, microsegmentation, and one-click containment tools are being used to keep systems operational even during an incident. Only 13 percent of organisations believe their cyber resilience exceeds what is required. Trevor helps us understand why this number remains low and where organisations should focus to shift from vulnerability to resilience. From evolving regulations to future applications of AI in security, this conversation covers what leaders need to know if they prepare for the next generation of cyber threats. To access Illumio’s full ransomware report, visit illumio.com. Is your cyber resilience strategy built for recovery, or just defense?

  --------  

  23:11
• 3271: Inside Poolside’s Mission to Reinvent Enterprise Software Engineering

  Amid the buzz of the AWS Summit in London, I sat down with Eiso Kant, the CTO and Co-Founder of Poolside, to explore how his team is reshaping the future of software development through AI. This conversation was recorded right on the show floor inside a surprisingly sleek podcast booth at the ExCel, where Eiso unpacked what sets Poolside apart in a space many claim to be in but few truly build for. Poolside is not just another AI company. It's one of a handful globally that is actually training foundation models from the ground up. While most firms are chasing general-purpose AI, Poolside has chosen a different path. They focus solely on empowering software developers inside high-consequence environments, such as banking, defense, and major global retailers. These are systems where precision and security matter, and where AI can drive measurable gains in productivity and reliability. What struck me during this discussion is how deliberately Poolside has been built for enterprise use from the start. Their model doesn’t just live in the cloud. It is designed to live within the customer’s own infrastructure, whether that’s in their private AWS environment or even on-prem. This focus on data privacy, security, and customizability is helping Poolside win trust where it counts most. And the partnership with AWS takes this a step further, making it easier for enterprises to deploy Poolside’s AI within existing cloud frameworks while meeting strict governance requirements. Eiso explained that Poolside doesn’t just throw larger models at problems. Instead, they use reinforcement learning from code execution, training on millions of real codebases and test suites. This approach helps the model go beyond autocomplete and simple bug fixes. It’s now stepping into longer, more complex tasks, nudging us closer to a future where AI could serve as a true teammate for software engineers. We also tackled one of the most important discussions in AI today: whether this is a cost-cutting tool or a productivity multiplier. Eiso didn't dodge the nuance. While some may use AI to reduce headcount, Poolside’s focus is on enabling companies to build more, ship faster, and innovate with greater speed. That shift is not about replacing people. It's about creating leverage for development teams under pressure to deliver more in less time. If you're a CTO, CIO, or engineering leader, this episode is packed with practical insights. Whether it's understanding the ROI of AI-assisted development, the importance of retaining control of your own models, or how to think about enterprise-grade security in the age of LLMs, there's a lot here to digest. So how should we really be thinking about AI in the enterprise? Is it a partner, a tool, or the beginning of an entirely new workforce paradigm? Tune in to find out.

  --------  

  25:10
• 3270: AI, Health Data, and the Vision Behind Zoe's New App

  What if the food you eat could not only affect how you feel today but also determine how many healthy years you’ll have in the future? In this episode of Tech Talks Daily, I sit down with Jonathan Wolf, the co-founder and CEO of Zoe, to explore how advanced science, AI, and data are reshaping our understanding of nutrition and health. Jonathan shares the remarkable journey of building Zoe from an idea into a leading science and nutrition company that has reached hundreds of thousands of users. From a background in physics and ad tech to pioneering personalized nutrition, Jonathan has led Zoe through significant milestones, including publishing more than 70 peer-reviewed papers and developing tools that empower individuals to understand their microbiomes, track real-time health markers, and make lasting changes to their diet. We also dive into the technology powering Zoe's new free app launch in the US, which aims to help consumers see what’s really in their food. Through food photo recognition, AI-driven analysis, and a unique risk scale for processed food, Zoe is offering a tool that could change how people choose what they eat. Jonathan explains why ultra-processed foods are a major public health concern and how empowering individuals with knowledge is the first step toward lasting change. Beyond product features, this conversation also unpacks the tension between rigorous scientific integrity and business growth, the importance of behavior change, and the broader implications for public health. Whether you're interested in the future of AI in healthcare, building a purpose-driven tech company, or simply making smarter food decisions, this episode will leave you thinking differently about what’s on your plate. How can personalized nutrition move from science labs into daily life, and what role should tech leaders play in that shift?

  --------  

  43:12
• 3269: Meet Frich and the Tech Driving Gen Z’s Financial Confidence

  How do you teach financial literacy to a generation that’s grown up swiping on social media, watching crypto rise and fall, and navigating economic uncertainty before they’ve even finished university? That’s the question Aleksandra Medina set out to answer when she co-founded Frich—a social finance app built with Gen Z in mind. In this episode, I sit down with Aleksandra, the CPO and co-founder of Frich, to explore how she and her team are redefining financial wellness for the next generation. Born out of a small New York apartment and their own shared frustrations with managing money, Frich isn’t your typical finance app. It gives users a way to benchmark their spending and saving against their peers, sparking conversations around topics often ignored—like how much support you’re getting from your parents, or whether you’re overpaying on rent compared to people your age. With over 800,000 users and partnerships with banks, credit unions, and fintechs, Frich has become a trusted tool in a space where many young people feel overlooked. Aleksandra explains how her role as Chief Product Officer puts her at the intersection of tech and impact, designing an app that’s as much about psychology and transparency as it is about numbers. We also talk about what it’s like raising funds as a first-time founder during a period of economic headwinds, and why Gen Z’s financial potential is often underestimated. Throughout our conversation, we explore why open dialogue is key to improving financial well-being and how Frich uses gamified, community-driven insights to make those dialogues easier and more fun. From daily polls to data-driven recommendations, the app flips the script on traditional financial advice, replacing lectures with real-world relevance. Is Gen Z as financially lost as some headlines suggest? Or are they simply lacking the right tools and data to guide their decisions? Frich is betting on the latter. Where are you benchmarking your financial reality? And how might a little more transparency change the way you approach money?  

  --------  

  38:20
• 3268 How CellVoyant is Predicting Cell Outcomes Before They Happen with AI

  In today’s episode, I had the opportunity to speak with Rafael Carazo Salas, a scientist, entrepreneur, and the CEO and founder of CellVoyant. This is a conversation that goes beyond the hype around AI to reveal how machine learning is reshaping the future of healthcare in ways that are both profound and immediate. CellVoyant, a spinout from the University of Bristol, is using AI and advanced imaging technology to solve one of the most persistent challenges in biotech: the cost, time, and complexity involved in developing cell therapies. Rafael explained how his team is applying real-time microscopy and predictive AI to monitor and guide cell behavior. This approach doesn’t rely on invasive techniques that destroy the very cells being studied. Instead, it enables a clearer path forward in cell therapy development by understanding how cells behave and adapt over time. We explored several impactful examples, from CAR-T therapies for blood cancers to emerging treatments for Parkinson’s disease and type 1 diabetes. Rafael drew comparisons to Google Maps, describing how CellVoyant’s platform builds dynamic roadmaps for cell development, allowing scientists to correct course in real time. It’s a shift in how we think about drug development, one that has the potential to lower costs and increase access to life-saving treatments. Beyond the science, Rafael shared his insights on the UK’s biotech ecosystem, the role of academic spinouts, and why now is a strategic moment for the UK to establish itself as a global leader in AI-powered biotech. As political and economic conditions shift in other parts of the world, he sees a window of opportunity to attract talent, drive innovation, and strengthen commercialisation. So how far can AI go in transforming biotech, and what role will companies like CellVoyant play in making advanced therapies available to all? Tune in to find out.

  --------  

  36:54

Plus de podcasts Technologies

Podcasts tendance de Technologies

À propos de Tech Talks Daily

Tech Talks Daily: Podcasts du groupe